Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 3, 2014, Pages 715-722

  Georg, Dietmar ^a,b   Hopfgartner, Johannes ^a,b   Gòra, Joanna ^a   Kuess, Peter ^a,b   Kragl, Gabriele ^a   Berger, Daniel ^a,b   Hegazy, Neamat ^a   Goldner, Gregor ^a,b   Georg, Petra ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; DOSE FRACTIONATION; FEMUR HEAD; HEAVY ION RADIOTHERAPY; HUMANS; MALE; ORGAN SPARING TREATMENTS; ORGANS AT RISK; PHOTONS; PROSTATIC NEOPLASMS; PROTON THERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; RELATIVE BIOLOGICAL EFFECTIVENESS; TUMOR BURDEN; URETHRA; URINARY BLADDER;

EID: 84893836010     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.11.241     Document Type: Article

References (35)

1. A. Jemal, R. Siegel, and J. Xu et al. Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. A. Al-Mamgani, W.D. Heemsbergen, and P.C. Levendag et al. Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial Radiother Oncol 96 2010 13 18
3. A.L. Zietman, K. Bae, and J.D. Slater et al. Randomized trial comparing conventional-dose with high dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09 J Clin Oncol 28 2010 1106 1111
4. P.A. Kupelian, L. Potters, and D. Khuntia et al. Radical prostatectomy, external beam radiotherapy <72Gy, external beam radiotherapy > or =72Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer Int J Radiat Oncol Biol Phys 58 2004 25 33 (Pubitemid 38010333)
5. M.J. Zelefsky, M. Kollmeier, and B. Cox et al. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer Int J Radiat Oncol Biol Phys 84 2012 125 129
6. R. Miralbell, S.A. Roberts, and E. Zubizarreta et al. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β=1.4 (0.9-2.2) Gy Int J Radiat Oncol Biol Phys 82 2012 e17 e24
7. H. Ishikawa, H. Tsuji, and T. Kamada et al. Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer Int J RadiatOncolBiol Phys 66 2006 1084 1091 (Pubitemid 44633528)
8. K. Akakura, H. Tsujii, and S. Morita et al. Phase I/II clinical trials of carbon ion therapy for prostate cancer Prostate 58 2004 252 258 (Pubitemid 38168922)
9. G. Goldner, R. Pötter, and J.J. Battermann et al. Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients Radiother Oncol 103 2012 223 227
10. P. Grimm, I. Billiet, and D. Bostwick et al. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group BJU Int 109 Suppl. 1 2012 22 29
11. P. Hoskin, A. Rojas, and G. Lowe et al. High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence Int J Radiat Oncol Biol Phys 82 2012 1376 1384
12. P.J. Hoskin, A. Colombo, and A. Henry et al. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update Radiother Oncol 107 2013 325 332
13. J.J. Coen, A.L. Zietman, and C.J. Rossi et al. Comparison of high-dose proton radiotherapy and brachytherapy in localizedprostate cancer: A case-matched analysis Int J Radiat Oncol Biol Phys 82 2012 e25 e31
14. W.D. Heemsbergen, A. Al-Mamgani, and M.G. Witte et al. Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs.78 Gy): Relationships with local dose, acute effects, and baseline characteristics Int J Radiat Oncol Biol Phys 78 2010 19 25
15. G.K. Hunter, C.A. Reddy, and E.A. Klein et al. Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer Prostate Cancer 2012 2012 853487
16. M.J. Zelefsky, X. Pei, and T. Teslova et al. Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: Incidence and cause-specific survival outcomes according to the initial treatment intervention BJU Int 110 2012 1696 1701
17. M. Stock, A. Palm, and A. Altendorfer et al. IGRT induced dose burden for a variety of imaging protocols at two different anatomical sites Radiother Oncol 102 2012 355 363
18. J. Góra, M. Stock, and C. Lütgendorf-Caucig et al. Is there an advantage in designing adapted, patient-specific PTV margins in intensity modulated proton beam therapy for prostate cancer? Int J Radiat Oncol Biol Phys 85 2013 881 888
19. T. Okada, H. Tsuji, and T. Kamada et al. Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: From 20 to 16 fractions Int J Radiat Oncol Biol Phys 84 2012 968 972
20. M. Krämer, O. Jäkel, and T. Haberer et al. Treatment planning for heavy-ion radiotherapy: Physical beam model and dose optimization Phys Med Biol 45 2000 3299 3317
21. D. Giantsoudi, D. Baltas, and A. Karabis et al. A gEUD-based inverse planning technique for HDR prostate brachytherapy: Feasibility study Med Phys 40 2013 041704
22. T.K. Podder, A.P. Dicker, and P. Hutapea et al. A novel curvilinear approach for prostate seed implantation Med Phys 39 2012 1887 1892
23. J.O. Deasy, A.I. Blanco, and V.H. Clark CERR: A computational environment for radiotherapy research Med Phys 30 2003 979 985 (Pubitemid 36578702)
24. I.R. Vogelius, and S.M. Bentsen Meta analysis of alpha/beta ratio for prostate cancer in the presence of an overall time factor. Bad news, good news or no news? Int J Radiat Oncology Biol Phys 85 2013 89 94
25. D.J. Brenner Fractionation and late rectal toxicity Int J Radiat Oncology Biol Phys 60 2004 1013 1015 (Pubitemid 39440782)
26. J.M. Michalski, H. Gay, and A. Jackson et al. Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncology Biol Phys 76 2010 123 129
27. Herrmann T, Baumann M, Dörr W, eds. Klinische Strahlenbiologie: Kurz und Bündig. 4th ed. Amsterdam: Elsevier-Urban-Fischer.
28. J. Dutreix The Role of Dose Rate in Brachytherapy 1997 Medical Physics Publishing Madison, WI 69 82
29. L. Budäus, M. Bolla, and A. Bossi et al. Functional outcomes and complications following radiation therapy for prostate cancer: A critical analysis of the literature Eur Urol 61 2012 112 127
30. K.M. Snyder, R.G. Stock, and S.M. Hong et al. Defining the risk of developing grade 2 proctitis following 125-I prostate brachytherapy using a rectal dose-volume histogram analysis Int J Radiat Oncol Biol Phys 50 2001 335 341 (Pubitemid 32475740)
31. A. Gómez-Iturriaga Piña, J. Crook, and J. Borg et al. Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with D(90) ≥180 Gy Int J Radiat Oncol Biol Phys 78 2010 422 427
32. K. Nihei, T. Ogino, and M. Onozawa et al. Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities Int J Radiat Oncol Biol Phys 81 2011 390 396
33. N.P. Mendenhall, Z. Li, and B.S. Hoppe et al. Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer Int J Radiat Oncol Biol Phys 82 2012 213 221
34. Y. Lievens, and M. Pijls-Johannesma Health economic controversy and cost-effectiveness of proton therapy Semin Radiat Oncol 23 2013 134 141
35. G. Bauman, M. Haider, and U.A. Van der Heide et al. Boosting imaging defined dominant prostatic tumors: A systematic review Radiother Oncol 107 2013 274 281